Selected research
Market Structure
Global NAD+ Booster Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global NAD+ Booster market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for NAD+ Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for NAD+ Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NAD+ Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for NAD+ Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of NAD+ Booster include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global NAD+ Booster market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of NAD+ Booster and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents NAD+ Booster sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Booster market size, projected growth trends, production technologies, key applications, and end-use industries.
NAD+ Booster Segment by Company
EffePharm
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
GeneHarbor
NOMON Co., Ltd. (Teijin)
Maac10 Formulas
Kingdomway
Herbalmax
Genex Formulas
EZZ
Elysium Health
Chromadex
CELFULL
Bontac
NAD+ Booster Segment by Type
Content <98%
Content ≥98%
NAD+ Booster Segment by Application
Health Care Products
Beauty Products
Others
NAD+ Booster Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Booster market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ Booster and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Booster.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the NAD+ Booster market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NAD+ Booster manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NAD+ Booster in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of NAD+ Booster in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Content <98%
- Content ≥98%
Applications
- Health Care Products
- Beauty Products
- Others
Companies covered
- EffePharm
- Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- GeneHarbor
- NOMON Co., Ltd. (Teijin)
- Maac10 Formulas
- Kingdomway
- Herbalmax
- Genex Formulas
- EZZ
- Elysium Health
- Chromadex
- CELFULL
- Bontac
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global NAD+ Booster Market Size, 2021 VS 2025 VS 2032
- 1.3 Global NAD+ Booster Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global NAD+ Booster Sales Estimates and Forecasts (2021-2032)
- 1.5 Global NAD+ Booster Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global NAD+ Booster Market Dynamics
- 2.1 NAD+ Booster Industry Trends
- 2.2 NAD+ Booster Industry Drivers
- 2.3 NAD+ Booster Industry Opportunities and Challenges
- 2.4 NAD+ Booster Industry Restraints
3 NAD+ Booster Market by Manufacturers
- 3.1 Global NAD+ Booster Revenue by Manufacturers (2021-2026)
- 3.2 Global NAD+ Booster Sales by Manufacturers (2021-2026)
- 3.3 Global NAD+ Booster Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global NAD+ Booster Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NAD+ Booster Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global NAD+ Booster Manufacturers, Product Type & Application
- 3.7 Global NAD+ Booster Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global NAD+ Booster Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 NAD+ Booster Players Market Share by Revenue in 2025
- 3.8.3 2025 NAD+ Booster Tier 1, Tier 2, and Tier 3
4 NAD+ Booster Market by Type
- 4.1 NAD+ Booster Type Introduction
- 4.1.1 Content <98%
- 4.1.2 Content ≥98%
- 4.2 Global NAD+ Booster Sales by Type
- 4.2.1 Global NAD+ Booster Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global NAD+ Booster Sales by Type (2021-2032)
- 4.2.3 Global NAD+ Booster Sales Market Share by Type (2021-2032)
- 4.3 Global NAD+ Booster Revenue by Type
- 4.3.1 Global NAD+ Booster Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global NAD+ Booster Revenue by Type (2021-2032)
- 4.3.3 Global NAD+ Booster Revenue Market Share by Type (2021-2032)
5 NAD+ Booster Market by Application
- 5.1 NAD+ Booster Application Introduction
- 5.1.1 Health Care Products
- 5.1.2 Beauty Products
- 5.1.3 Others
- 5.2 Global NAD+ Booster Sales by Application
- 5.2.1 Global NAD+ Booster Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global NAD+ Booster Sales by Application (2021-2032)
- 5.2.3 Global NAD+ Booster Sales Market Share by Application (2021-2032)
- 5.3 Global NAD+ Booster Revenue by Application
- 5.3.1 Global NAD+ Booster Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global NAD+ Booster Revenue by Application (2021-2032)
- 5.3.3 Global NAD+ Booster Revenue Market Share by Application (2021-2032)
6 Global NAD+ Booster Sales by Region
- 6.1 Global NAD+ Booster Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global NAD+ Booster Sales by Region (2021-2032)
- 6.2.1 Global NAD+ Booster Sales by Region (2021-2026)
- 6.2.2 Global NAD+ Booster Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America NAD+ Booster Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America NAD+ Booster Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe NAD+ Booster Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe NAD+ Booster Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific NAD+ Booster Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific NAD+ Booster Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa NAD+ Booster Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa NAD+ Booster Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global NAD+ Booster Revenue by Region
- 7.1 Global NAD+ Booster Revenue by Region
- 7.1.1 Global NAD+ Booster Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global NAD+ Booster Revenue by Region (2021-2026)
- 7.1.3 Global NAD+ Booster Revenue by Region (2027-2032)
- 7.1.4 Global NAD+ Booster Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America NAD+ Booster Revenue (2021-2032)
- 7.2.2 North America NAD+ Booster Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe NAD+ Booster Revenue (2021-2032)
- 7.3.2 Europe NAD+ Booster Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific NAD+ Booster Revenue (2021-2032)
- 7.4.2 Asia-Pacific NAD+ Booster Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa NAD+ Booster Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa NAD+ Booster Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 EffePharm
- 8.1.1 EffePharm Company Information
- 8.1.2 EffePharm Business Overview
- 8.1.3 EffePharm NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 EffePharm NAD+ Booster Product Portfolio
- 8.1.5 EffePharm Recent Developments
- 8.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- 8.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
- 8.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
- 8.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Product Portfolio
- 8.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
- 8.3 GeneHarbor
- 8.3.1 GeneHarbor Company Information
- 8.3.2 GeneHarbor Business Overview
- 8.3.3 GeneHarbor NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GeneHarbor NAD+ Booster Product Portfolio
- 8.3.5 GeneHarbor Recent Developments
- 8.4 NOMON Co., Ltd. (Teijin)
- 8.4.1 NOMON Co., Ltd. (Teijin) Company Information
- 8.4.2 NOMON Co., Ltd. (Teijin) Business Overview
- 8.4.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Product Portfolio
- 8.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
- 8.5 Maac10 Formulas
- 8.5.1 Maac10 Formulas Company Information
- 8.5.2 Maac10 Formulas Business Overview
- 8.5.3 Maac10 Formulas NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Maac10 Formulas NAD+ Booster Product Portfolio
- 8.5.5 Maac10 Formulas Recent Developments
- 8.6 Kingdomway
- 8.6.1 Kingdomway Company Information
- 8.6.2 Kingdomway Business Overview
- 8.6.3 Kingdomway NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kingdomway NAD+ Booster Product Portfolio
- 8.6.5 Kingdomway Recent Developments
- 8.7 Herbalmax
- 8.7.1 Herbalmax Company Information
- 8.7.2 Herbalmax Business Overview
- 8.7.3 Herbalmax NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Herbalmax NAD+ Booster Product Portfolio
- 8.7.5 Herbalmax Recent Developments
- 8.8 Genex Formulas
- 8.8.1 Genex Formulas Company Information
- 8.8.2 Genex Formulas Business Overview
- 8.8.3 Genex Formulas NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Genex Formulas NAD+ Booster Product Portfolio
- 8.8.5 Genex Formulas Recent Developments
- 8.9 EZZ
- 8.9.1 EZZ Company Information
- 8.9.2 EZZ Business Overview
- 8.9.3 EZZ NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 EZZ NAD+ Booster Product Portfolio
- 8.9.5 EZZ Recent Developments
- 8.10 Elysium Health
- 8.10.1 Elysium Health Company Information
- 8.10.2 Elysium Health Business Overview
- 8.10.3 Elysium Health NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Elysium Health NAD+ Booster Product Portfolio
- 8.10.5 Elysium Health Recent Developments
- 8.11 Chromadex
- 8.11.1 Chromadex Company Information
- 8.11.2 Chromadex Business Overview
- 8.11.3 Chromadex NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Chromadex NAD+ Booster Product Portfolio
- 8.11.5 Chromadex Recent Developments
- 8.12 CELFULL
- 8.12.1 CELFULL Company Information
- 8.12.2 CELFULL Business Overview
- 8.12.3 CELFULL NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 CELFULL NAD+ Booster Product Portfolio
- 8.12.5 CELFULL Recent Developments
- 8.13 Bontac
- 8.13.1 Bontac Company Information
- 8.13.2 Bontac Business Overview
- 8.13.3 Bontac NAD+ Booster Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bontac NAD+ Booster Product Portfolio
- 8.13.5 Bontac Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 NAD+ Booster Value Chain Analysis
- 9.1.1 NAD+ Booster Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 NAD+ Booster Production Mode & Process
- 9.2 NAD+ Booster Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 NAD+ Booster Distributors
- 9.2.3 NAD+ Booster Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst